US5874424A
(en)
*
|
1995-12-20 |
1999-02-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US6204261B1
(en)
*
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
US5798355A
(en)
*
|
1995-06-07 |
1998-08-25 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity
|
US5846981A
(en)
*
|
1993-05-28 |
1998-12-08 |
Gpi Nil Holdings Inc. |
Inhibitors of rotamase enzyme activity
|
US6420522B1
(en)
*
|
1995-06-05 |
2002-07-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US6699869B1
(en)
|
1995-03-24 |
2004-03-02 |
Myriad Genetics Inc. |
β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
|
US6245764B1
(en)
|
1995-03-24 |
2001-06-12 |
Molecumetics Ltd. |
β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
|
US6020331A
(en)
*
|
1995-03-24 |
2000-02-01 |
Molecumetics, Ltd. |
β-sheet mimetics and use thereof as protease inhibitors
|
AU5122196A
(en)
*
|
1995-03-31 |
1996-10-16 |
Takeda Chemical Industries Ltd. |
Cysteine protease inhibitor
|
US5696135A
(en)
*
|
1995-06-07 |
1997-12-09 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
|
US5859031A
(en)
*
|
1995-06-07 |
1999-01-12 |
Gpi Nil Holdings, Inc. |
Small molecule inhibitors of rotamase enzyme activity
|
US5744451A
(en)
*
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
US5801197A
(en)
*
|
1995-10-31 |
1998-09-01 |
Gpi Nil Holdings, Inc. |
Rotamase enzyme activity inhibitors
|
US5843904A
(en)
*
|
1995-12-20 |
1998-12-01 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1βconverting enzyme
|
US5834457A
(en)
*
|
1996-01-26 |
1998-11-10 |
The Regents Of The University Of California |
Method of modulating radical formation by mutant cuznsod enzymes
|
ES2262184T3
(es)
*
|
1996-08-05 |
2006-11-16 |
Myriad Genetics, Inc. |
Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.
|
EP1661566A3
(en)
*
|
1996-08-05 |
2008-04-16 |
Myriad Genetics, Inc. |
Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
|
US6117896A
(en)
*
|
1997-02-10 |
2000-09-12 |
Molecumetics Ltd. |
Methods for regulating transcription factors
|
US5869519A
(en)
*
|
1996-12-16 |
1999-02-09 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
US5786378A
(en)
*
|
1996-09-25 |
1998-07-28 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters
|
US5801187A
(en)
*
|
1996-09-25 |
1998-09-01 |
Gpi-Nil Holdings, Inc. |
Heterocyclic esters and amides
|
US6218424B1
(en)
|
1996-09-25 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Heterocyclic ketone and thioester compounds and uses
|
US6194435B1
(en)
|
1996-10-11 |
2001-02-27 |
Cor Therapeutics, Inc. |
Lactams as selective factor Xa inhibitors
|
US6063794A
(en)
|
1996-10-11 |
2000-05-16 |
Cor Therapeutics Inc. |
Selective factor Xa inhibitors
|
US5919790A
(en)
*
|
1996-10-11 |
1999-07-06 |
Warner-Lambert Company |
Hydroxamate inhibitors of interleukin-1β converting enzyme
|
US6369080B2
(en)
|
1996-10-11 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
WO1998016505A1
(en)
|
1996-10-11 |
1998-04-23 |
Warner-Lambert Company |
SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
|
PL332704A1
(en)
*
|
1996-10-11 |
1999-09-27 |
Warner Lambert Co |
Sulphonamide-group substituted derivatives of aspartic acid as inhibitors of an interleukin-1beta transforming enzyme
|
US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
SI0932617T1
(en)
*
|
1996-10-18 |
2002-06-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
HU227742B1
(en)
|
1996-10-18 |
2012-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
CN1088706C
(zh)
*
|
1996-10-25 |
2002-08-07 |
卫福有限公司 |
新型杂环酰胺化合物及其医药用途
|
PT944645E
(pt)
|
1996-12-06 |
2005-06-30 |
Vertex Pharma |
Inibidores da enzima conversora de interleucina 1beta
|
CA2274250A1
(en)
*
|
1996-12-06 |
1998-06-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1.beta. converting enzyme
|
EP1466921A1
(en)
*
|
1996-12-06 |
2004-10-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1 beta converting enzyme
|
US6184244B1
(en)
|
1996-12-16 |
2001-02-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
US5877197A
(en)
*
|
1996-12-16 |
1999-03-02 |
Karanewsky; Donald S. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
US5846979A
(en)
|
1997-02-28 |
1998-12-08 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic esters, amides, thioesters, and ketones
|
US6054487A
(en)
*
|
1997-03-18 |
2000-04-25 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
JP2001523226A
(ja)
|
1997-04-14 |
2001-11-20 |
シーオーアール セラピューティクス インコーポレイテッド |
選択的Xa因子阻害剤
|
AU6896398A
(en)
|
1997-04-14 |
1998-11-11 |
Cor Therapeutics, Inc. |
Selective factor xa inhibitors
|
WO1998046628A1
(en)
*
|
1997-04-14 |
1998-10-22 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
HUP9700816A3
(en)
*
|
1997-04-28 |
1999-06-28 |
Gyogyszerkutato Intezet |
3(r)-3-amino-4-carboxy-butiraldehyde derivatives inhibiting release of interleukin-1-beta
|
FR2766188B1
(fr)
*
|
1997-07-15 |
2000-02-11 |
Hoechst Marion Roussel Inc |
Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes
|
US6228854B1
(en)
|
1997-08-11 |
2001-05-08 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6333321B1
(en)
|
1997-08-11 |
2001-12-25 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6218382B1
(en)
|
1997-08-11 |
2001-04-17 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
ES2221227T3
(es)
*
|
1997-11-24 |
2004-12-16 |
MERCK & CO., INC. |
Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
WO1999031066A1
(en)
*
|
1997-12-18 |
1999-06-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyridones as src family sh2 domain inhibitors
|
ATE296812T1
(de)
|
1998-03-09 |
2005-06-15 |
Vertex Pharma |
1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
|
HU227920B1
(en)
*
|
1998-03-19 |
2012-06-28 |
Vertex Pharma |
Inhibitors of caspases, pharmaceutical compositions comprising thereof and their use
|
GB9809664D0
(en)
*
|
1998-05-06 |
1998-07-01 |
Hoffmann La Roche |
a-Ketoamide derivatives
|
US7338976B1
(en)
|
1998-08-14 |
2008-03-04 |
Gpi Nil Holdings, Inc. |
Heterocyclic esters or amides for vision and memory disorders
|
US6335348B1
(en)
|
1998-08-14 |
2002-01-01 |
Gpi Nil Holdings, Inc. |
Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
|
US6506788B1
(en)
|
1998-08-14 |
2003-01-14 |
Gpi Nil Holdings, Inc. |
N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
US6399648B1
(en)
|
1998-08-14 |
2002-06-04 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
|
US6218423B1
(en)
|
1998-08-14 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Pyrrolidine derivatives for vision and memory disorders
|
US6333340B1
(en)
|
1998-08-14 |
2001-12-25 |
Gpi Nil Holdings, Inc. |
Small molecule sulfonamides for vision and memory disorders
|
US6339101B1
(en)
|
1998-08-14 |
2002-01-15 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
|
US6337340B1
(en)
|
1998-08-14 |
2002-01-08 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
|
US6395758B1
(en)
|
1998-08-14 |
2002-05-28 |
Gpi Nil Holdings, Inc. |
Small molecule carbamates or ureas for vision and memory disorders
|
US6384056B1
(en)
|
1998-08-14 |
2002-05-07 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters or ketones for vision and memory disorders
|
US6559304B1
(en)
|
1998-08-19 |
2003-05-06 |
Vertex Pharmaceuticals Incorporated |
Method for synthesizing caspase inhibitors
|
US6177565B1
(en)
|
1998-08-19 |
2001-01-23 |
Vertex Pharmaceuticals Inc. |
Process for synthesizing piperazic acid
|
US6201118B1
(en)
|
1998-08-19 |
2001-03-13 |
Vertex Pharmaceuticals Inc. |
Process for forming an N-acylated, N,N-containing bicyclic ring from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor
|
US6462072B1
(en)
|
1998-09-21 |
2002-10-08 |
Gpi Nil Holdings, Inc. |
Cyclic ester or amide derivatives
|
JP2003524603A
(ja)
*
|
1998-10-06 |
2003-08-19 |
スミスクライン・ビーチャム・コーポレイション |
カスパーゼおよびアポトーシス
|
EP1135406A1
(en)
|
1998-12-02 |
2001-09-26 |
Merck Frosst Canada & Co. |
Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
|
EP1159273A1
(en)
|
1999-03-02 |
2001-12-05 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compounds useful as reversible inhibitors of cathepsin s
|
TW200404789A
(en)
*
|
1999-03-15 |
2004-04-01 |
Axys Pharm Inc |
Novel compounds and compositions as protease inhibitors
|
US6724942B1
(en)
|
1999-05-24 |
2004-04-20 |
Fuji Photo Film Co., Ltd. |
Image processing method and system
|
DE60031686T2
(de)
*
|
1999-07-19 |
2007-08-30 |
Merck Frosst Canada Ltd., Kirkland |
Pyrazinone, diese verbindungen enthaltende zusammenstellungen
|
US6420364B1
(en)
|
1999-09-13 |
2002-07-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compound useful as reversible inhibitors of cysteine proteases
|
US7253169B2
(en)
|
1999-11-12 |
2007-08-07 |
Gliamed, Inc. |
Aza compounds, pharmaceutical compositions and methods of use
|
US6417189B1
(en)
|
1999-11-12 |
2002-07-09 |
Gpi Nil Holdings, Inc. |
AZA compounds, pharmaceutical compositions and methods of use
|
US6358928B1
(en)
|
1999-11-22 |
2002-03-19 |
Enzyme Systems Products |
Peptidyl sulfonyl imidazolides as selective inhibitors of serine proteases
|
AU2001257006A1
(en)
*
|
2000-04-11 |
2001-10-23 |
Du Pont Pharmaceuticals Company |
Substituted lactams as inhibitors of abeta protein production
|
WO2001087328A2
(en)
*
|
2000-05-12 |
2001-11-22 |
Immunex Corporation |
Interleukin-1 inhibitors in the treatment of diseases
|
PE20011350A1
(es)
*
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
|
IL147629A0
(en)
|
2000-06-01 |
2002-08-14 |
Bristol Myers Squibb Pharma Co |
LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
WO2001094351A1
(en)
|
2000-06-07 |
2001-12-13 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
SV2003000617A
(es)
*
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US7205327B2
(en)
|
2000-11-21 |
2007-04-17 |
Vertex Pharmaceuticals Incorporated |
Imidazole and benzimidazole caspase inhibitors and uses thereof
|
US6653295B2
(en)
|
2000-12-13 |
2003-11-25 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus NS3 protease
|
AU2002230763A1
(en)
*
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
AUPR215700A0
(en)
*
|
2000-12-19 |
2001-01-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Carboxylic acid compound having cyclopropane ring
|
DE10105040A1
(de)
*
|
2001-02-05 |
2002-08-14 |
Tell Pharm Ag Hergiswil |
Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
|
DE10105041A1
(de)
*
|
2001-02-05 |
2002-08-14 |
Tell Pharm Ag Hergiswil |
Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
|
DE10105039A1
(de)
*
|
2001-02-05 |
2002-08-08 |
Tell Pharm Ag Hergiswil |
Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
|
US20050192228A1
(en)
*
|
2001-02-05 |
2005-09-01 |
Jean Rapin |
Tripeptide derivatives for the treatment of neurodegenerative diseases
|
DE10105038B4
(de)
*
|
2001-02-05 |
2005-07-07 |
Neurotell Ag |
Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
|
WO2002094787A1
(en)
|
2001-05-23 |
2002-11-28 |
Ucb, S.A. |
2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
JP2005170790A
(ja)
*
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
N−アルキルスルフォニル置換アミド誘導体
|
US7410956B2
(en)
*
|
2002-02-11 |
2008-08-12 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitor prodrugs
|
WO2003068237A1
(en)
|
2002-02-14 |
2003-08-21 |
Myriad Genetics, Inc. |
Beta-sheet mimetics and composition and methods relating thereto
|
CN1656237A
(zh)
*
|
2002-04-22 |
2005-08-17 |
马里兰大学,巴尔的摩县 |
衣壳蛋白的抗病毒抑制
|
US7138395B2
(en)
*
|
2002-06-10 |
2006-11-21 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
US7001899B2
(en)
*
|
2002-06-10 |
2006-02-21 |
The Procter & Gamble Company |
Interleukin converting enzyme inhibitors
|
AU2003243657A1
(en)
|
2002-06-26 |
2004-01-19 |
Bristol-Myers Squibb Company |
Amino-bicyclic pyrazinones and pyridinones
|
EP1539762A2
(en)
*
|
2002-06-26 |
2005-06-15 |
Bristol-Myers Squibb Company |
Bicyclic pyrimidinones as coagulation cascade inhibitors
|
CN100503572C
(zh)
|
2002-06-28 |
2009-06-24 |
沃泰克斯药物股份有限公司 |
天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途
|
TW200500343A
(en)
*
|
2002-12-20 |
2005-01-01 |
Vertex Pharma |
Caspase inhibitors and uses thereof
|
PE20050159A1
(es)
*
|
2003-05-27 |
2005-04-19 |
Vertex Pharma |
Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
|
AR045596A1
(es)
|
2003-09-05 |
2005-11-02 |
Vertex Pharma |
Inhibidores de proteasas de serina en particular proteasa ns3-ns4a del vhc
|
AU2011226946B2
(en)
*
|
2004-02-27 |
2012-05-03 |
Vertex Pharmaceuticals Incoporated |
Caspase Inhibitors and Uses Thereof
|
RU2382780C2
(ru)
|
2004-02-27 |
2010-02-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы каспаз и их применение
|
CN1942466B
(zh)
*
|
2004-02-27 |
2011-02-23 |
沃泰克斯药物股份有限公司 |
天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途
|
WO2005090334A2
(en)
|
2004-03-12 |
2005-09-29 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
|
WO2005115362A1
(en)
*
|
2004-05-15 |
2005-12-08 |
Vertex Pharmaceuticals Incorporated |
Treating seizures using ice inhibitors
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
EP1778221A2
(en)
*
|
2004-05-27 |
2007-05-02 |
Vertex Pharmaceuticals Incorporated |
Ice inhibitors for the treatment of autoinflammatory diseases
|
CN101098855B
(zh)
|
2004-11-24 |
2012-06-06 |
沃泰克斯药物股份有限公司 |
3-[2-(3-酰氨基-2-氧代-2h-吡啶-1-基)-乙酰氨基]-4-氧代-戊酸衍生物及其作为天冬氨酸特异性半胱氨酸蛋白酶抑制剂的用途
|
WO2006126730A1
(ja)
*
|
2005-05-26 |
2006-11-30 |
Ajinomoto Co., Inc. |
二環式ピリミジン化合物及びその製造方法
|
NZ566022A
(en)
|
2005-07-28 |
2011-04-29 |
Vertex Pharma |
Caspase inhibitor prodrugs
|
AU2006275413B2
(en)
*
|
2005-08-02 |
2012-07-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
*
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
WO2007098270A2
(en)
|
2006-02-27 |
2007-08-30 |
Vertex Pharmaceuticals Incorporated |
Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
|
BRPI0709567A2
(pt)
*
|
2006-03-16 |
2011-07-12 |
Vertex Pharma |
inibidores deuterados de protease de hepatite c
|
AP2009004960A0
(en)
*
|
2007-02-27 |
2009-08-31 |
Vertex Pharma |
Co-crystals and pharmaceutical compositions comprising the same
|
NZ579295A
(en)
*
|
2007-02-27 |
2012-03-30 |
Vertex Pharma |
Inhibitors of serine proteases
|
US8492546B2
(en)
*
|
2007-08-30 |
2013-07-23 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
TW200920355A
(en)
*
|
2007-09-06 |
2009-05-16 |
Lexicon Pharmaceuticals Inc |
Compositions and methods for treating immunological and inflammatory diseases and disorders
|
US8598346B2
(en)
*
|
2008-07-16 |
2013-12-03 |
Bitop Ag |
Synthesis of cyclic amidines
|
WO2012061785A2
(en)
|
2010-11-05 |
2012-05-10 |
Brandeis University |
Ice inhibiting compounds and uses thereof
|
HU1000676D0
(en)
|
2010-12-17 |
2011-02-28 |
Pharmahungary 2000 Kft |
Inhibitors of matrix metalloproteinase, pharmaceutical compositions thereof and use of them for preventing and treating diseases where the activation of mmp is involved
|
US9956260B1
(en)
|
2011-07-22 |
2018-05-01 |
The J. David Gladstone Institutes |
Treatment of HIV-1 infection and AIDS
|
JP6243908B2
(ja)
*
|
2012-08-23 |
2017-12-06 |
アリオス バイオファーマ インク. |
パラミクソウイルス感染症を治療するための化合物
|
AR103297A1
(es)
|
2014-12-30 |
2017-05-03 |
Forma Therapeutics Inc |
Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
|
MA41291A
(fr)
|
2014-12-30 |
2017-11-07 |
Forma Therapeutics Inc |
Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
|
EP3253738A1
(en)
|
2015-02-05 |
2017-12-13 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
WO2016126935A1
(en)
|
2015-02-05 |
2016-08-11 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
JP2018504431A
(ja)
|
2015-02-05 |
2018-02-15 |
フォーマ セラピューティクス,インコーポレイテッド |
ユビキチン特異的プロテアーゼ7阻害物質としてのチエノピリミジノン
|
JP2023530267A
(ja)
|
2020-06-10 |
2023-07-14 |
アリゴス セラピューティクス インコーポレイテッド |
コロナウイルス、ピコルナウイルス及びノロウイルス感染を治療するための抗ウイルス化合物
|
KR20240035513A
(ko)
|
2021-07-09 |
2024-03-15 |
알리고스 테라퓨틱스 인코포레이티드 |
항바이러스 화합물
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|